Cargando…
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is yet to be controlled worldwide, especially in India. The second wave of coronavirus disease 2019 (COVID-19) led to panic and confusion in India, owing to the overwhelming number of the population that fell prey to...
Autores principales: | Azhar, Asim, Khan, Wajihul Hasan, Khan, Parvez Anwar, Alhosaini, Khaled, Owais, Mohammad, Ahmad, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855610/ https://www.ncbi.nlm.nih.gov/pubmed/35216920 http://dx.doi.org/10.1016/j.jiph.2022.02.007 |
Ejemplares similares
-
GPCRs: The most promiscuous druggable receptor of the mankind
por: Alhosaini, Khaled, et al.
Publicado: (2021) -
Mucormycosis and COVID-19 an epidemic in a pandemic?
por: Banerjee, Indrajit, et al.
Publicado: (2021) -
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions
por: Khan, Wajihul Hasan, et al.
Publicado: (2021) -
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
por: Khan, Wajihul Hasan, et al.
Publicado: (2022) -
Post-COVID mucormycosis: Ascertainment of the pathological diagnostic approach
por: Sood, Anubhuti, et al.
Publicado: (2021)